This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Sign In   |   Register
News
Filter news by category:

Recent events, essential information and the latest EAS news.

Displaying page 1 of 3
1  |  2  |  3

Publications
Monday 7 October 2019
Breaking news - Rare Lipid Disorder Statement published »
New European Atherosclerosis Society Task Force Statement on rare lipid dyslipidaemias Advances in gene testing offer a...
Saturday 31 August 2019
New ESC/EAS Dyslipidaemia Guidelines out now - what is new? »
The 2019 Joint European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) Dyslipidaemia Guidelines were r...
Wednesday 18 September 2019   (0 Comments - view/add)
Diet & Lifestyle in management of dyslipidaemia & CVD - Survey Key Points now available »
Survey about the knowledge and interest of EAS Members on the role of diet and lifestyle in the management of dyslipidaemi...
Monday 16 September 2019   (0 Comments - view/add)
EAS Commentary on the First insights from the EAS FH Registry »
First data from the European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration Registry were pr...
Sunday 1 September 2019   (0 Comments - view/add)
Video interview: What’s new in the guidelines: LDL goals in high and very high-risk patients »
The 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk, were p...
Tuesday 27 August 2019   (0 Comments - view/add)
Journal highlights July: Biomarkers are important tools »
In our regular feature, Editor-in-Chief Arnold von Eckardstein highlights interesting articles from recent issues of Ather...
Friday 12 July 2019   (0 Comments - view/add)
Journal highlights June: Management of CVD risk by lowering of plasma cholesterol »
In our regular feature, Editor-in-Chief Arnold von Eckardstein highlights interesting articles from recent issues of Ather...
Tuesday 11 June 2019   (0 Comments - view/add)
Journal Highlights May - studies on atherosclerosis »
In our regular feature, Editor-in-Chief Arnold von Eckardstein highlights interesting articles from recent issues of Ather...
Tuesday 7 May 2019   (0 Comments - view/add)
Journal highlights March/April on state of the art of HDL in the management of ASCVD »
In our regular feature, Editor-in-Chief Arnold von Eckardstein highlights interesting articles from recent issues of Ather...
Friday 26 April 2019   (0 Comments - view/add)
Commentary: Novel therapeutics specific to lipoprotein(a) »
Novel therapeutics specific to lipoprotein(a) are now available and offer the means to test the ‘lipoprotein(a) hypothesis...
Monday 25 March 2019   (0 Comments - view/add)
Journal highlights on developments in gene regulation »
In our regular feature, Editor-in-Chief Arnold von Eckardstein highlights interesting articles from recent issues of Ather...
Friday 22 March 2019   (0 Comments - view/add)
Try Rapid Communications - Atherosclerosis journal »
If your high-quality article has received a rejection from a top-tier journal, consider submission to Atherosclerosis as a...
Friday 8 March 2019   (0 Comments - view/add)
Journal highlights on history & development of atherosclerotic diseases »
In our regular feature, Editor-in-Chief Arnold von Eckardstein highlights interesting articles from recent issues of Ather...
Thursday 21 February 2019   (0 Comments - view/add)
Commentary: Triglycerides and cardiovascular risk: apolipoprotein B holds the key »
In a recent Mendelian randomization study, the clinical benefit from treatments that lower LDL cholesterol or triglyceride...
Thursday 31 January 2019   (0 Comments - view/add)
Journal highlights December on clinical risk predictions »
In our regular feature, Editor-in-Chief Arnold von Eckardstein highlights interesting articles from recent issues of Ather...
Tuesday 15 January 2019   (0 Comments - view/add)
Your feedback important - joint ESC/EAS survey on current beliefs and practices in lipid management »
The joint ESC/EAS task force needs your input concerning your views and practice patterns regarding lipid management....
Monday 14 January 2019   (0 Comments - view/add)
A look back at 2018: What made the news? A featured Commentary by Jane K. Stock »
This new commentary, by EAS Scientific writer Jane K. Stock, discusses highlights from clinical trials reporting in 2018;...
Monday 7 January 2019   (0 Comments - view/add)
EAS announces Atherosclerosis: X - the open access mirror journal of Atherosclerosis »
We are glad to announce the release of a fully open access mirror journal of Atherosclerosis named Atherosclerosis: X ....
Thursday 20 December 2018   (0 Comments - view/add)
Journal highlights November on ASCVD in children and adolescents »
In our regular feature, Editor-in-Chief Arnold von Eckardstein highlights interesting articles from recent issues of Ather...
Thursday 29 November 2018   (0 Comments - view/add)
Commentary on Lipid guidelines in the USA and Europe: A meeeting of the minds? »
After a five year wait, the American College of Cardiology and American Heart Association published new guidelines for the...
Thursday 22 November 2018   (0 Comments - view/add)
Journal highlights October on Global care of FH, measurement of LDL cholesterol and more FH articles »
In our regular feature, Editor-in-Chief Arnold von Eckardstein and Simona Negrini highlight interesting articles from rece...
Friday 19 October 2018   (0 Comments - view/add)
Journal highlights September on inflammation and its interaction with lipoproteins »
In addition to lipid accumulation, inflammation is a hallmark of atherosclerotic lesions. The present issue of Atheroscler...
Thursday 27 September 2018   (0 Comments - view/add)
Commentary September: Cholesterol & inflammatory risk: insights from secondary & primary prevention »
Low-density lipoprotein cholesterol is indisputably causal for cardiovascular disease, and a major modifiable risk factor....
Monday 17 September 2018   (0 Comments - view/add)
Journal highlights August on lifestyle, obesity, insulin sensitivity, diabetes, non-alcoholic ... »
This issue of Atherosclerosis contains several articles describing the interactions of lifestyle, obesity, insulin sensiti...
Thursday 13 September 2018   (0 Comments - view/add)
Commentary August: Optimal cardiovascular health: also good for the brain »
Optimal cardiovascular health from an early age has a beneficial impact on long-term cardiometabolic risk, conferring gain...
Tuesday 14 August 2018   (0 Comments - view/add)
Journal hightlights July on lifestyle factors and cardiovascular risk »
Volume 274 Issue July 2018 By Simona Negrini and Arnold von Eckardstein (Editor–in-Chief) . This issue...
Monday 6 August 2018   (0 Comments - view/add)
New Joint Consensus Initiative on Quantifying Atherogenic Lipoproteins »
The last decade has seen a revolution in the management of low-density lipoprotein cholesterol (LDL-C), the guideline-reco...
Tuesday 10 July 2018   (0 Comments - view/add)
Journal highlights June - HDL and Valve disease »
Volume 273 Issue June 2018 By Simona Negrini and Arnold von Eckardstein (Editor–in-Chief) . High-densit...
Thursday 31 May 2018   (0 Comments - view/add)
Society journal news: Rapid Communication »
Atherosclerosis journal - Rapid Communications If your high-quality article has received a rejection from a to...
Tuesday 29 May 2018   (0 Comments - view/add)
Journal highlights May - Hypertriglyceridemia, hyperglycemia and hyperuricemia »
Volume 272 Issue May 2018 By Simona Negrini and Arnold von Eckardstein (Editor–in-Chief) . Hypertriglyc...
Thursday 24 May 2018   (0 Comments - view/add)
Editorial "Highlights of EAS Congress Lisbon" »
As ever, the European Atherosclerosis Society (EAS) Congress delivered on its promise for news in atherosclerosis and card...
Friday 4 May 2018   (0 Comments - view/add)
Journal Highlights April - atherosclerotic cardiovascular diseases (ASCVD) risk »
Volume 271 Issue April 2018 By Simona Negrini and Arnold von Eckardstein (Editor–in-Chief) . Diabetes...
Thursday 3 May 2018
SAMS & Statins - new Clinicians handbook app now available »
New Clinicians hanbook app, now available to download Statin-Associated Muscle Symptoms (SAMS): Definition, Assess...
Friday 27 April 2018   (0 Comments - view/add)
New EAS Consensus Panel Statement addresses persistent questions on long-term statin safety »
Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase [HMG-CoA] inhibitors) are recommended by guidelines as first-line...
Monday 9 April 2018   (0 Comments - view/add)
Editorial "At the end of the ODYSSEY…what now for PCSK9 inhibition in practice?" »
In March, the second of the cardiovascular outcomes studies with a PCSK9 inhibitor reported, showing significant clinical...

Displaying page 1 of 3
1  |  2  |  3

Visiting Address
Mässans Gata 10, SE-412 51, Göteborg
Post to be addressed to
Box 5243, SE-402 24, Göteborg, SWEDEN

Organisation number: 802418-0427

Telephone
+46(0)31 760 24 27

Fax
+46(0)31 81 20 22

Email
office@eas-society.org

Foot Logo
 
©2018 European Atherosclerosis Society | EAS Data handling policy (GDPR)
Membership Software Powered by YourMembership  ::  Legal